KORU Medical Systems Inc (OQ:KRMD)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 17, 2024 07:00 am ET

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2024 financial results on Wednesday, May 1, 2024. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Apr 11, 2024 04:05 pm ET

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

Mar 18, 2024 05:24 pm ET

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, is pleased to announce data on the impact of the Freedom Infusion System on subcutaneous immunoglobulin (SCIg) therapy for primary immunodeficiency diseases (PIDD) to be presented at the National Home Infusion Association (NHIA) 2024 Conference. The conference will take place from March 23 to 27 in Austin, Texas.

Mar 13, 2024 04:05 pm ET

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2023. The Company also issued guidance for the full year 2024.

Mar 11, 2024 04:05 pm ET

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced a collaboration with a global pharmaceutical manufacturer to initiate a feasibility study with KORU’s Freedom Infusion System for an already commercialized rare disease therapy.

Mar 06, 2024 07:00 am ET

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, is pleased to announce a clinical supply agreement for a novel subcutaneous immunoglobulin (SCIg) drug entering Phase 3 trials. The custom product developed for this clinical trial under a prior agreement was built off the foundation of the KORU Medical Freedom System and tailored to meet the unique subcutaneous infusion administration

Feb 21, 2024 07:00 am ET

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will report fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Nov 29, 2023 07:00 am ET

KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023.

Nov 28, 2023 08:00 am ET

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced it will host an investor day at the Mahwah, NJ headquarters on Tuesday, December 5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time. The event will include presentations by members of management and an expert immunologist. The presentations will cover KORU Medical’s key markets, gr

Nov 08, 2023 04:10 pm ET

KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced a development agreement with a biopharmaceutical manufacturer for KORU Medical to develop and seek regulatory approval for a next-generation infusion system for its subcutaneous immunoglobulin (SCIg) therapy.

Nov 08, 2023 04:08 pm ET

KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer

Nov 08, 2023 04:05 pm ET

KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook

Nov 07, 2023 04:05 pm ET

KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced that it received U.S. Food and Drug Administration (FDA) clearance for use of the FREEDOM60® Infusion System with Hizentra® 50 mL prefilled syringes (PFS).

Nov 02, 2023 04:05 pm ET

KORU Medical Systems to Participate in Upcoming Investor Conferences

Oct 25, 2023 04:05 pm ET

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will report third quarter 2023 financial results on Wednesday, November 8, 2023. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Oct 05, 2023 07:05 am ET

KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, is pleased to announce its participation in the Immunoglobulin National Society (“IGNS”) 2023 National Conference, taking place in Denver, Colorado from October 5th to 8th. KORU Medical will present two abstracts during the conference, furthering its commitment to advancing re

Oct 04, 2023 04:05 pm ET

KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced that Edward Wholihan was appointed to the Company's Board of Directors on September 28, 2023 to fill the vacancy that followed the Company's 2023 Annual Meeting of Shareholders.

Sep 15, 2023 08:05 am ET

KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase on September 21, 2023.

Aug 09, 2023 04:05 pm ET

KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook

Aug 08, 2023 04:05 pm ET

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023.

Aug 02, 2023 05:15 pm ET

KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced preliminary unaudited revenues for the second quarter 2023 and provided business, outlook and executive updates.

Jul 31, 2023 04:05 pm ET

KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will report second quarter 2023 financial results on Wednesday, August 9, 2023. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Jul 27, 2023 04:05 pm ET

KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions, today announced an agreement with a biopharmaceutical company to validate its FREEDOM™ Infusion System for use with the biopharma company’s drug, a novel biologic. Under terms of the Agreement, Koru Medical will validate the Freedom Infusion System for use with the company’s drug. The drug developer is expected to begin Phase III studies by the end of 2023 for treatment of a rare geneti

Jul 10, 2023 07:01 am ET

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced that it has submitted a 510(k) premarket notification submission to the U.S. Food and Drug Administration for the use of its FREEDOM60® Infusion System with Hizentra® 50 mL prefilled syringes.

Jun 27, 2023 07:05 am ET

KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer

May 04, 2023 04:01 pm ET

KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results

Apr 21, 2023 07:01 am ET

KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, 2023. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Mar 08, 2023 04:01 pm ET

KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today reported financial results for the fourth quarter and full year ended December 31, 2022. The Company also issued guidance for the full year 2023.

Feb 22, 2023 04:01 pm ET

KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report fourth quarter and full year 2022 financial results on Wednesday, March 8, 2023. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Jan 25, 2023 07:01 am ET

KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced a development agreement with a pharmaceutical manufacturer of subcutaneous immunoglobulin therapy (SCIg) to develop and seek regulatory approval of the Freedom Infusion System with an SCIg prefilled syringe.

Nov 21, 2022 07:01 am ET

KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1st, 2022.

Nov 10, 2022 04:01 pm ET

KORU Medical Systems to Participate in Upcoming Investor Conferences

Nov 09, 2022 04:01 pm ET

KORU Medical Systems Announces 2022 Third Quarter Financial Results

Nov 08, 2022 07:01 am ET

KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions, today announced the progression of its agreement with Kira Pharmaceuticals, including expansion into three important additional indications.

Oct 26, 2022 04:01 pm ET

KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report third quarter 2022 financial results on Wednesday, November 9, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Oct 17, 2022 04:01 pm ET

KORU Medical Systems to Participate in Upcoming Industry Conferences

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions, today announced the Company will participate in upcoming industry conferences including the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference and the 12th Annual Partnership Opportunities in Drug Delivery (PODD®).

Oct 12, 2022 07:01 am ET

KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous (SQ) infusion solutions, today announced the appointment of Brent Rutland as the Company’s new Vice President of Medical Affairs. Mr. Rutland will provide leadership in the Company’s clinical and data generation strategies, key opinion leader engagement, assessing new subcutaneous drug candidates for use with the Company’s products and overseeing the medical affairs team. Additionally, Mr. Rutland will be

Oct 05, 2022 07:01 am ET

KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its membership in the Subcutaneous (SC) Drug Development & Delivery Consortium (the “Consortium”), making it one of the first device companies to be added to the Consortium.

Aug 03, 2022 04:01 pm ET

KORU Medical Systems Announces 2022 Second Quarter Financial Results

Jul 20, 2022 04:01 pm ET

KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report second quarter 2022 financial results on Wednesday, August 3, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

May 04, 2022 04:01 pm ET

KORU Medical Systems Announces 2022 First Quarter Financial Results

May 02, 2022 04:01 pm ET

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion system to deliver pegcetacoplan 20 mL solution, branded as EMPAVELI® or Aspaveli® and commercialized by Apellis in the United States and by Sobi outside the United States.

Apr 20, 2022 04:01 pm ET

KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report first quarter 2022 financial results on Wednesday, May 4, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Apr 18, 2022 05:00 pm ET

KORU Medical Systems Appoints Brian Case As Chief Technology Officer

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Brian Case, a veteran medical technology R&D leader with over 20 years of experience, as the Company’s new Chief Technology Officer. Mr. Case will lead product development and innovation as the Company defines and executes a technology strategy to support a global drug delivery portfolio.

Mar 02, 2022 04:01 pm ET

KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results

Feb 22, 2022 12:30 am ET

CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022

First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report fourth quarter and full year 2021 financial results on Wednesday, March 2, 2022. [instead of Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on th

Feb 16, 2022 04:01 pm ET

KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2021

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report fourth quarter and full year 2021 financial results on Wednesday, March 2, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Dec 21, 2021 04:01 pm ET

KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced FDA 510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.

Dec 01, 2021 04:01 pm ET

KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day

Nov 10, 2021 04:03 pm ET

KORU Medical Systems Announces 2021 Third Quarter Financial Results

Nov 10, 2021 04:00 pm ET

KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion pump to deliver Hizentra® [immune globulin subcutaneous (human) 20% liquid] 20 mL prefilled syringes. Hizentra® is the most prescribed subcutaneous Ig product and the first to be available in a prefilled syrin

Nov 09, 2021 07:00 am ET

KORU Medical Systems to Participate in Two Upcoming Conferences

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its participation in two upcoming conferences, Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and the 33rd Annual Piper Sandler Healthcare Conference.

Nov 08, 2021 07:00 am ET

KORU Medical Announces Collaboration With Gilero to Accelerate Innovation

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing and commercialization of innovative and easy-to-use home infusion solutions, today announced its collaboration with Gilero, a medical device design and manufacturing company. Gilero offers unparalleled engineering and manufacturing solutions and has been a trusted partner for medical and drug delivery device companies for 20 years. The collaboration is part of KORU Medical’s strategic focus on innovation as the

Nov 01, 2021 07:00 am ET

KORU Medical Expands Senior Team to Accelerate Growth Strategy

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of two new leaders who will be responsible for key elements of the Company's growth strategy: Rob Cannon as the Company's new Vice President of Sales, and Brian Hertzog as the Company's new Vice President of BioPharma Business Development. Mr. Cannon will be responsible for U.S. sales and increasing the overall penetration of subcutaneous th

Oct 27, 2021 04:01 pm ET

KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report third quarter 2021 financial results on Wednesday, November 10, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Oct 26, 2021 07:00 am ET

KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Chris Pazdan as the Company's new Vice President of Quality Assurance and Regulatory Affairs. Mr. Pazdan will be responsible for all quality assurance and regulatory affairs as the Company continues to build out a robust Quality Management System and a regulatory strategy to meet evolving global standards.

Aug 11, 2021 04:01 pm ET

KORU Medical Systems Announces 2021 Second Quarter Financial Results

Aug 09, 2021 07:00 am ET

KORU Medical Systems to Participate in Canaccord Genuity’s 41st Annual Growth Conference

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will participate in Canaccord Genuity’s 41st Annual Growth Conference.

Jul 28, 2021 07:00 am ET

KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report second quarter 2021 financial results on Wednesday, August 11, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Jun 28, 2021 01:05 pm ET

Lifshitz Law Firm, P.C. Announces Investigations of, CleanSpark, Inc. (NasdaqGS: CLSK), The Geo Group, Inc. (NYSE: GEO), Repro Med Systems, Inc. (NasdaqGS: KRMD), and Romeo Power, Inc. (NYSE: RMO)

CleanSpark, Inc. (NasdaqGS: CLSK) Lifshitz Law Firm, P.C. announces that a class action complaint was filed against CLSK alleging that CLSK failed to disclose to investors: (1) that the Company had overstated its customer and contract figures;...

May 25, 2021 09:05 am ET

KRMD FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors to Secure Counsel Before Important May 25 Deadline – KRMD

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Repro Med Systems, Inc. (NASDAQ: KRMD) between August 4, 2020 and January 25, 2021, inclusive (the “Class Period”), of the important May 25, 2021 lead...

May 25, 2021 08:00 am ET

Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Repro-Med Systems, Inc. (NASDAQ: KRMD) investors that acquired shares between August 4, 2020 and January 25, 2021. Investors have until May 25, 2021 to...

May 24, 2021 11:30 am ET

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD)

The Law Offices of Frank R. Cruz reminds investors of the upcoming May 25, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) (NASDAQ:

May 21, 2021 11:00 am ET

DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

May 20, 2021 11:00 am ET

Last Few Days to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) (“KORU” or "the Company") (NASDAQ: KRMD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired KORU securities between August 4, 2020 and January 25, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:

May 19, 2021 11:25 pm ET

SHAREHODLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline – KRMD

Pomerantz LLP announces that a class action lawsuit has been filed against Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) (NASDAQ: KRMD) and certain of its officers. The class action, filed in the United States...

May 19, 2021 10:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON), Repro Med Systems, Inc. d/b/a KORU...

May 18, 2021 05:30 pm ET

KRMD FINAL DEADLINE ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Repro Med Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – KRMD

May 17, 2021 11:25 am ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

May 14, 2021 12:00 pm ET

DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

May 14, 2021 10:00 am ET

KRMD Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Repro-Med Systems, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

May 13, 2021 10:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm

May 13, 2021 09:33 pm ET

Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

May 12, 2021 08:00 pm ET

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KRMD

May 12, 2021 04:02 pm ET

KORU Medical Systems Announces 2021 First Quarter Financial Results

May 12, 2021 02:28 pm ET

SHAREHOLDER ALERT: Robbins LLP Announces that Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) Was Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP announces that a purchaser of KORU Medical Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between August 4, 2020 and January 25, 2

May 11, 2021 12:05 pm ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

May 10, 2021 11:30 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 25, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Repro Med Systems, Inc. d/b/a KORU...

May 07, 2021 01:59 pm ET

Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

May 05, 2021 10:21 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lordstown Motors, Root, Vroom, and Repro Med and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lordstown Motors Corp. (NASDAQ: RIDE), Root, Inc. (NASDAQ: ROOT), Vroom, Inc....

May 04, 2021 01:30 pm ET

DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

May 03, 2021 01:00 pm ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Apr 30, 2021 10:10 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) - KRMD

Pomerantz LLP is investigating claims on behalf of investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) (“KORU” or the “Company”) (NASDAQ: KRMD). Such investors are advised to contact Robert S. Willoughby at [email protected] or...

Apr 28, 2021 04:11 pm ET

KORU Medical Systems to Report First Quarter 2021 Financial Results on May 12, 2021

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report first quarter 2021 financial results on Wednesday, May 12, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Apr 28, 2021 04:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lordstown Motors, Root, Vroom, and Repro Med and Encourages Investors to Contact the Firm

Apr 28, 2021 10:00 am ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Apr 28, 2021 10:00 am ET

ROOT, VRM & KRMD Looming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Apr 26, 2021 11:30 am ET

DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Apr 24, 2021 08:48 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) - KRMD

Apr 24, 2021 06:00 pm ET

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KRMD

Apr 23, 2021 11:00 am ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Apr 21, 2021 07:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Repro Med, SOS Limited, Canoo, and Kadmon Holdings and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD), SOS Limited...

Apr 21, 2021 02:29 pm ET

Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Investors with losses are encouraged to contact the firm before May 25, 2021; click here to submit trade information The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Repro-Med Systems, Inc. (NASDAQ:...

Apr 20, 2021 08:15 pm ET

KRMD INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Repro Med Systems, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KRMD

Apr 16, 2021 08:10 pm ET

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KRMD

Apr 16, 2021 11:00 am ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Apr 15, 2021 12:30 pm ET

DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Apr 14, 2021 11:55 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) - KRMD

Apr 14, 2021 07:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lordstown Motors, Root, Vroom, and Repro Med and Encourages Investors to Contact the Firm

Apr 14, 2021 11:00 am ET

KRMD Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Repro-Med Systems, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) (“KORU” or "the Company") (NASDAQ: KRMD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired KORU securities between August 4, 2020 and January 25, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:

Apr 13, 2021 02:37 pm ET

Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Apr 12, 2021 05:57 pm ET

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KRMD

Apr 12, 2021 10:00 am ET

KRMD Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Repro-Med Systems, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Apr 09, 2021 09:00 am ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Apr 05, 2021 01:30 pm ET

DEADLINE ALERT for CYDY, ROOT, VRM, KRMD: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Apr 03, 2021 04:45 pm ET

ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages Repro Med Systems, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – KRMD

Apr 01, 2021 11:00 am ET

DEADLINE ALERT for ROOT, VRM, and KRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Apr 01, 2021 08:30 am ET

REPRO MED SYSTEMS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed in the United States District Court for t

Wolf Haldenstein Adler Freeman & Hers LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of persons and entities that purchased or...

Mar 31, 2021 09:00 pm ET

REPRO MED ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Repro Med Systems, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) securities between August 4, 2020 and January 25, 2021, inclusive (the “Class Period”). Investors have until May 25, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Mar 31, 2021 05:57 pm ET

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Repro Med Systems, Inc. (KRMD)

Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Repro Med Systems, Inc. (“Repro Med”) (NASDAQ: KRMD) in the United States District Court for the Southern District of New York on behalf of those who purchased...

Mar 31, 2021 12:00 pm ET

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD)

Law Offices of Howard G. Smith reminds investors of the upcoming May 25, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) (NASDAQ: KRMD) securities between August 4, 2020 and January 25, 2021, inclusive (the

Mar 30, 2021 03:43 pm ET

KRMD INVESTOR ALERT: Rosen Law Firm Encourages Repro Med Systems, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – KRMD

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Repro Med Systems, Inc. (NASDAQ: KRMD) between August 4, 2020 and January 25, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 25, 2021.

Mar 30, 2021 02:54 pm ET

SHAREHOLDER ALERT: Robbins LLP Announces That Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) is Being Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP announces that a purchaser of Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between August 4, 2020 and January 25, 2021. KORU

Mar 30, 2021 01:00 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD)

Mar 29, 2021 11:00 am ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) (NASDAQ: KRMD) securities between August 4, 2020 and January 25, 2021, inclusive (the “Class Period”). KORU investors have until May 25, 2021

Mar 29, 2021 09:53 am ET

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess o

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or “the Company”) (NASDAQ:

Mar 26, 2021 07:00 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) (NASDAQ: KRMD) investors concerning the Company’s possible violations of federal securities laws.

Mar 26, 2021 05:00 pm ET

KRMD CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Humenik v. Repro Med Systems, Inc. d/b/a KORU Medical Systems, et al., (Case No. 21-cv-02632) on behalf of persons and entities that purchased or otherwise

Mar 26, 2021 04:34 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KURO” or “the Company”) (NASDAQ:

Mar 26, 2021 02:14 pm ET

KRMD CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems

Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Humenik v. Repro Med Systems, Inc. d/b/a KORU Medical Systems, et al., (Case No. 21-cv-02632) on behalf of persons and entities that purchased or otherwis

Mar 25, 2021 09:07 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) (NASDAQ:

Mar 23, 2021 04:01 pm ET

KORU Medical Systems Reports Fourth Quarter and Full Year 2020 Financial Results

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company") a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the fourth quarter and full year ended December 31, 2020.

Mar 19, 2021 08:00 am ET

KORU Medical Systems Announces New Chief Executive Officer

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that help improve quality of life for patients, today announced that Linda Tharby has been appointed President and Chief Executive Officer and will succeed Interim CEO Jim Beck effective April 12, 2021. Mr. Beck will continue to serve on KORU's Board of Directors.

Mar 08, 2021 04:01 pm ET

KORU Medical Systems to Report Fourth Quarter and Full Year 2020 Financial Results on March 23, 2021

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report fourth quarter and full year 2020 financial results on March 23, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Jan 28, 2021 09:00 am ET

The Law Offices of Frank R. Cruz Announces Investigation of Repro Med Systems, Inc. dba KORU Medical Systems (KRMD) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Repro Med Systems, Inc. dba KORU Medical Systems (“KORU Medical” or the “Company”) (NASDAQ:

Jan 25, 2021 04:01 pm ET

KORU Medical Systems Reports Preliminary Full Year 2020 Results; Announces CEO Transition

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported preliminary financial results for the full year ended December 31, 2020. The Company also announced that seasoned home infusion executive and KORU Medical Board member, Jim Beck, has been appointed Interim Chief Executive Officer, effective immediately. Don Pettigrew has resi

Jan 11, 2021 08:10 am ET

KORU Medical Systems to Present at H.C. Wainwright BioConnect 2021 Conference

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Executive Officer, will provide a company overview at the H.C. Wainwright BioConnect 2021 Conference, held virtually from January 11-14, 2021. A copy of the presentation will be available on the “Investors” section of the Company’s website

Nov 16, 2020 05:03 pm ET

KORU Medical Systems Announces Stock Repurchase Program

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that its Board of Directors has authorized a stock repurchase program under which the Company may purchase up to $10 million of its outstanding common stock through December 31, 2021.

Nov 03, 2020 06:17 pm ET

KORU Medical Systems Announces Financial Results for Third Quarter 2020

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the third quarter ended September 30, 2020 (“Q3 2020”).

Oct 27, 2020 09:15 am ET

KORU Medical Systems Schedules Release of Third Quarter 2020 Financial Results and Conference Call

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the third quarter ended September 30, 2020 after the close of the financial markets on Tuesday, November 3, 2020. Management will host a conference call on Wednesday, November 4, 2020 at 9:00 am ET to discuss the results and business activities.

Aug 10, 2020 04:15 pm ET

KORU Medical Systems to Present at Canaccord Genuity 40th Annual Growth Conference

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Executive Officer, and Karen Fisher, Chief Financial Officer, are scheduled to present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020 at 1:00 pm ET.

Aug 04, 2020 05:34 pm ET

KORU Medical Systems Announces 2020 Second Quarter Financial Results

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the second quarter ended June 30, 2020 (“Q2 2020”).

Jul 27, 2020 09:20 am ET

KORU Medical Systems Schedules Release of Second Quarter 2020 Financial Results and Conference Call

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the second quarter ended June 30, 2020 after the close of the financial markets on Tuesday, August 4, 2020. Management will host a conference call on Wednesday, August 5, 2020 at 9:00 am ET to discuss the results and business activities.

Jul 08, 2020 08:30 am ET

KORU Medical Systems Appoints Josh Bennett VP Global Commercialization

Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) today announced the appointment of Josh Bennett to the newly created position of Vice President Global Commercialization. Mr. Bennett brings 20 years of healthcare management and consulting experience to KORU Medical. He will be responsible for creating and executing initiatives designed to accelerate KORU Medical’s growth, with a focus on business development and product commercialization. Mr. Bennett will report directly to Don Pettigrew, President and CEO of KORU Medical.

Jun 19, 2020 07:50 am ET

KORU Medical Prices Public Offering of Common Stock

Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (“KORU Medical”) today announced the pricing of its previously announced underwritten public offering of 3,125,000 shares of its common stock at a public offering price of $8.00 per share. The gross proceeds to KORU Medical before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $25 million. In connection with the offering, KORU Medical has granted the underwriters a 30-day option to purchase up to an additional 468,750 shares at the public offering price, les

Jun 18, 2020 04:43 pm ET

KORU Medical Systems to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) today announced that the Company is set to join the broad market Russell 3000® Index, the Russell 2000® Index, and Russell Microcap® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the U.S. stock market opens on June 29, 2020, based on a preliminary list of additions made public on June 5, 2020.

Jun 18, 2020 04:02 pm ET

KORU Medical Commences Public Offering of Common Stock

Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (“KORU Medical”) today announced that it has commenced an underwritten public offering of the sale of its shares of common stock. In connection with this offering, KORU Medical intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering. All of the shares are being offered by KORU Medical.

May 26, 2020 08:00 am ET

KORU Medical Systems and EMED Technologies Corporation Announce Settlement of All Pending Litigation

Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) and EMED Technologies Corporation (“EMED”) today announced the settlement of all ongoing litigation between the two companies, including patent, antitrust, unfair business practice, and other business tort claims.

May 04, 2020 04:52 pm ET

KORU Medical Systems Announces 2020 First Quarter Financial Results

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the first quarter ended March 31, 2020 (“Q1 2020”).

Apr 20, 2020 04:10 pm ET

KORU Medical Systems Schedules Release of First Quarter 2020 Financial Results and Conference Call

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the first quarter ended March 31, 2020 after the close of the financial markets on Monday, May 4, 2020. Management will host a conference call on Tuesday, May 5, 2020 at 9:00 am ET to discuss the results and business activities.

Apr 13, 2020 04:15 pm ET

United States Federal Court of Appeals Rules in Favor of KORU Medical Systems

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that on April 9, 2020 The United States Court of Appeals for the Federal Circuit (“the Federal Circuit Court”) affirmed an earlier decision by the United States District Court for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) that granted KORU Medical’s motion for summary judgement of non-infringement against EMED Technologies (“EMED”).

Feb 25, 2020 04:15 pm ET

KORU Medical Systems Announces Record 2019 Fourth Quarter and Full Year Financial Results

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the fourth quarter (“Q4 2019”) and full year ended December 31, 2019.

Feb 11, 2020 04:10 pm ET

KORU Medical Systems Schedules 2019 Fourth Quarter and Full Year Financial Results and Conference Call

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019 after the close of the financial markets on Tuesday, February 25, 2020. Management will host a conference call on Wednesday, February 26, 2020 at 9:00 am ET to discuss the results and business activities.

Feb 10, 2020 04:15 pm ET

KORU Medical Systems to Ring Nasdaq Closing Bell on February 12, 2020

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President & CEO, will ring the Nasdaq Closing Bell on Wednesday, February 12, 2020 at 4:00 pm ET.

Nov 14, 2019 04:10 pm ET

Magistrate Judge Issues Report and Recommendation to Award KORU Medical Systems $1.0 Million in Attorneys’ Fees and Costs

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that on November 12, 2019 a United States District Court Magistrate Judge for the Southern District of New York issued a Report and Recommendation that KORU Medical’s motion to declare the patent infringement case exceptional and recoup attorneys’ fees and expenses from EMED Technologies (“EMED”) should be granted in the amount of $1,012,527.67. As previously announced, on August 30, 2019 the United States District Court for the Southern District of New York granted KORU Med

Nov 07, 2019 04:10 pm ET

KORU Medical Systems to Present at November Investor Conferences

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that management is scheduled to present at the following investor conferences in November:

Nov 05, 2019 04:40 pm ET

KORU Medical Systems Announces Record 2019 Third Quarter Financial Results

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (the “Company”) today announced financial results for the third quarter (“Q3 2019”) ended September 30, 2019.

Oct 28, 2019 09:05 am ET

KORU Medical Systems Schedules 2019 Third Quarter Financial Results and Conference Call

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that it will release its financial results for the third quarter and nine months ended September 30, 2019 after the close of the financial markets on Tuesday, November 5, 2019. Management will host a conference call on Wednesday, November 6, 2019 at 9:00 am ET to discuss the results and business activities.

Oct 25, 2019 09:15 am ET

KORU Medical Systems to Present Poster Featuring HIgH-Flo Super26™ Needle Set at IgNS 2019 National Conference

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the Company”) today announced a poster presentation at the IgNS 2019 National Conference in Las Vegas that evaluates the performance of the Company’s HIgH-Flo Super26™ Subcutaneous Safety Needle Set (HIgH-Flo Super26™) against that of the Company’s standard HIgH-Flo™ 26G Needle Set in areas including patient infusion time, tolerability, comfort, and overall satisfaction.

You are here

KORU Medical Systems Inc (OQ:KRMD)

Business Focus: Medical Equipment, Supplies & Distribution